The 92 kDa type IV collagenase (MMP-9), which degrades type IV collagen, has been implicated in tissue remodeling. The purpose of the current study was to determine the role of Jun amino-terminal kinase (JNK)-and extracellular signal-regulated kinase-(ERK)-dependent signaling cascades in the regulation of MMP-9 expression. Towards this end, we ®rst determined the transcriptional requirements for MMP-9 promoter activity in a cell line (UM-SCC-1) which is an avid secretor of this collagenase. Transfection of these cells with a CAT reporter driven by progressive 5' deleted fragments of the MMP-9 promoter indicated the requirement of a region spanning 7144 to 773 for optimal promoter activity. DNase I footprinting revealed a protected region of the promoter spanning nucleotides 791 to 768 and containing a consensus AP-1 motif at 779. Mutation of this AP-1 motif practically abolished the activity of the MMP-9 promoter-driven CAT reporter. Mobility shift assays indicated c-Fos and Jun-D bound to this motif and transfection of the cells with a mutated c-Jun, which quenches the function of endogenous Jun and Fos proteins, decreased MMP-9 promoter activity by 80%. UM-SCC-1 cells contained a constitutively activated JNK and the expression of a kinasede®cient JNK1 reduced the activity of a CAT reporter driven either by the MMP-9 promoter or by three tandem AP-1 repeats upstream of a thymidine kinase minimal promoter. Conditioned medium collected from UM-SCC-1 cells transfected with the dominant negative JNK1 expression vector diminished 92 kDa gelatinolysis. Similarly, interfering with MEKK, which lies upstream of JNK1, using a dominant negative expression vector reduced MMP-9 promoter activity over the same concentration range which repressed the AP-1-thymidine kinase CAT reporter construct. UM-SCC-1 cells also contained a constitutively activated ERK1. MMP-9 expression, as determined by CAT assays and by zymography, was reduced by the co-expression of a kinase-de®cient ERK1. Interfering with MEK1, which is an upstream activator of ERK1, either with PD 098059, which prevents the activation of MEK1, or with a dominant negative expression construct, reduced 92 kDa gelatinolysis and MMP-9 promoter activity respectively. c-Raf-1 is an upstream activator of MEK1 and a kinasede®cient c-Raf-1 expression construct decreased the activity of a promoter driven by either the MMP-9 promoter or three tandem AP-1 repeats. Conversely, treatment of UM-SCC-1 cells with PMA, which activates c-Raf-1, increased 92 kDa gelatinolysis. These data suggest that MMP-9 expression in UM-SCC-1 cells, is regulated by JNK-and ERK-dependent signaling pathways.
Introduction
The 92 kDa type IV collagenase (gelatinase B also known as MMP-9) plays a major role in cell migration in both physiological and pathological processes (Hurwitz et al., 1993; Bernhard et al., 1994; Matrisian, 1992) such as tumor cell invasion by facilitating the destruction of the type IV collagencontaining basement membrane which separates the epithelial and stromal compartments (Tryggvason et al., 1987) . The 92 kDa type IV collagenase is secreted as a proenzyme (Wilhelm et al., 1989) and subsequently activated by multiple enzymes including cathepsin G, trypsin, stromelysin 1 (Okada et al., 1992; Shapiro et al., 1995) and 72 kDa gelatinase A (MMP-2) (Fridman et al., 1995) by the removal of 73 amino acids from the amino terminus of the protease. The active enzyme, which is capable of digesting native type I, III, IV and V collagens at nondenaturing temperatures (Wilhelm et al., 1989; Tracey and Cerami, 1994) , consists of ®ve domains; the amino-terminal and zinc-binding domains shared by all members of the metalloproteinase family, a collagen-binding ®bronectin-like domain, a carboxyterminal hemopexin-like domain and a unique 54 amino acid long proline-rich domain homologous to the a2 chain of type V collagen (Wilhelm et al., 1989) .
MMP-9 is encoded by a 7.7 kb gene which spans 13 exons (Collier et al., 1991; Huhtala et al., 1991) . Transcription of the gene, which yields a 2.3 kb mRNA (Wilhelm et al., 1989) , is regulated by 670 base pairs of upstream sequence which includes motifs corresponding to AP-1 (7533, 779), NF-kB (7600), PEA3 (PEA3 is an Ets family member) (7540) and Sp1 binding sites (7558). Indeed, one or more of these binding sites have been implicated in mediating the eects of a diverse set of agents which includes TNF-a , EGF, TGF-a, phorbol ester (Lyons et al., 1993) v-src and Ha-Ras . For example, we recently showed that the stimulation of MMP-9 expression by Ha-Ras required juxtaposed PEA3 and AP-1 motifs located 540 and 533 base pairs upstream of the transcriptional start site respectively . Sato and co-workers demonstrated that the stimulation of the MMP-9 promoter by v-src was mediated through an AP-1 motif and a GT box located 79 and 54 nucleotides upstream of the transcriptional start site respectively. On the other hand, the increased expression of this collagenase brought about by phorbol ester and by TNF-a involved an NF-kB and an Sp1 binding site at 7600 and 7558 respectively in addition to the AP-1 motif at 779 .
While the studies cited above have focused on determining the transcriptional requirements for MMP-9 expression, there is relatively little information on the signaling pathways which connect the cell surface to the nuclear transcriptional machinery regulating the expression of this collagenase. The activity and/or synthesis of several transcription factors in the AP-1, Ets and Rel/NF-kB (Whitmarsh et al., 1995; Cavigelli et al., 1995; Hibi et al., 1993; Minden et al., 1994b; Meyer et al., 1996) families have recently been shown to be regulated by Jun amino terminal kinases (JNKs also referred to as SAPKs) (Derijard et al., 1994) . The JNKs represent a subset of the mitogen-activated protein kinase (MAPK) family. The JNKs are activated by the dual activity kinase JNK kinase (JNKK1 also known as MKK4) (Lin et al., 1995a) which, in turn, is stimulated by a serinethreonine kinase MEKK (Minden et al., 1996) . The latter transduces the signals from both Ras-dependent (Minden et al., 1994a) and Ras-independent (Winston et al., 1995) (e.g. TNF-a) growth factor/cytokine cell surface receptors.
Alternatively, the synthesis and/or activity of transcription factors in the AP-1 (Gille et al., 1992; Pulverer et al., 1991; Bogoyevitch et al., 1995; Agarwal et al., 1995) , Ets (Agarwal et al., 1995; Rao and Reddy, 1993) and NF-kB (Li and Sedivy, 1993 ) families can be regulated by an extracellular signal-regulated kinase (ERK)-dependent signaling cascade. The ERKs are a subgroup of the MAPK family which are distantly related to the JNKs (Hibi et al., 1993; Derijard et al., 1994) . However, the regulation of ERK activity is distinct from that of the JNKs. Thus, the activity of ERK1 and ERK2 is dependent on their phosphorylation by the dual activity protein kinase MEK1 (also referred to as MAPKK) (Minden et al., 1994a; Crews et al., 1992) . MEK1, in turn, is stimulated by the serine-threonine kinase c-Raf-1 (Huang et al., 1993) . In contrast, the activity of MEK1 is relatively unaected by MEKK (responsible for JNKK1 activation) (Minden et al., 1994a) . c-Raf-1 is a down-stream eector of Ras (Kolch et al., 1991; Kyriakis et al., 1992; Jelinek et al., 1994) and protein kinase C (Sozeri et al., 1992) .
Considering that MMP-9 expression has been previously shown to require DNA motifs recognized by transactivators which themselves are substrates for the JNKs and ERKs, we undertook a study to determine the role of JNK-and ERK-dependent signaling modules in the regulation of expression of this collagenase.
Results
Activation of the MMP-9 promoter in UM-SCC-1 cells requires a proximal AP-1 motif We previously (Lengyel et al., 1995) demonstrated that the squamous cell carcinoma cell line UM-SCC-1 was an avid secretor of MMP-9. To determine the transcriptional requirements for activation of the promoter the following experiments were carried out. First, UM-SCC-1 cells were transiently transfected with a CAT reporter driven by 670 base pairs of 5' anking sequence or 5' deleted fragments of the promoter and subsequently assayed for CAT activity (Figure 1a) . The CAT reporter fused to 670 nucleotides of regulatory sequence was strongly activated in UM-SCC-1 cells. While progressive deletions of sequences from the 5' end resulted in a gradual decrease in promoter activity, a dramatic (12-fold) reduction in CAT activity was apparent with 73 base pairs (construct 773) when compared with 144 base pairs (construct 7144) of 5'¯anking sequence. These results indicated that while the maximal activation of the promoter required sequences spread over the length of the MMP-9 promoter, a nucleotide sequence residing between 7144 and 773 was critical for promoter stimulation. To identify the proteinbinding sequences in this region of the promoter, DNase I footprinting was performed. UM-SCC-1 nuclear extract was incubated with a radiolabeled fragment of the MMP-9 promoter spanning nucleotides 7144 to +1 and subsequently with DNase I (Figure 1b) . At least two regions of this sequence were footprinted. The ®rst of these spanned nucleotides 791 to 768 (thus including the region shown to be required for optimal MMP-9 promoter activity ± see Figure 1a ) and contained a consensus AP-1 motif (TGAGTCA) at position 779. The second protected region (764 to 744) contained a GT-box at 754. Site-directed mutagenesis of these motifs dramatically reduced promoter activation in UM-SCC-1 cells (Figure 1c ). Both of these transcription factor-binding sites have been previously implicated in the stimulation of MMP-9 expression by Ha-Ras and by v-src . In fact, to the knowledge of the authors, all studies to date have demonstrated a critical requirement of this AP-1 motif in the transcriptional regulation of MMP-9 expression this being regardless of cell type or stimulus Gum et al., 1996; . Mutation of NF-kB and Sp1 motifs at 7600 and 7558 respectively, both of which are important for the stimulation of MMP-9 promoter activity by phorbol ester , also impaired activation of the MMP-9 promoter in UM-SCC-1 cells although to a lesser extent. Interestingly, while we recently reported that juxtaposed PEA3/AP-1 motifs located at 7540 and 7533, respectively, were critical for the stimulation of MMP-9 gene expression by HaRas in OVCAR-3 ovarian cancer cells , mutation of either of these binding sites had only a minor eect on the constitutive activation of this promoter in UM-SCC-1 cells (Figure 1c) .
Considering the importance of the proximal AP-1-binding motif in the regulation of MMP-9 promoter activity in UM-SCC-1 and other cell types Gum et al., 1996; , electrophoretic mobility shift assays (EMSA) were carried out to identify UM-SCC-1 derived nuclear factors bound to this site. Nuclear extract from UM-SCC-1 cells was incubated with an end-labeled oligonucleotide spanning nucleotides 791 to 760 thus containing the AP-1 motif located at 779. The reaction mixture was then subjected to electrophoresis in a polyacrylamide gel (Figure 2a) . A binding complex of the oligonucleotide and nuclear extracted proteins was observed (arrow). This oligonucleotide-containing complex was speci®c for the AP-1 motif since the retarded band could be eliminated with a 100-fold excess of an unlabeled wild type oligonucleotide (wt competitor) but not with an equivalent amount of an oligonucleotide in which the AP-1 motif had been mutated (mt competitor). Incubation of the reaction mixture with an antibody speci®c for Jun-D supershifted the oligonucleotide-containing complex. Similarly, addition of a c-Fos-speci®c antibody to the reaction mixture supershifted the oligonucleotidebound complex indicating the presence of this transcription factor. In contrast, antibodies speci®c for Fra-1, Fra-2, Jun-B, c-Jun and ATF-2 did not discernibly alter complex formation., These data indicated that the proximal AP-1 motif at 779 in the MMP-9 promoter binds Jun-D and c-Fos transcription factors and it is possible that transactivation of this collagenase in UM-SCC-1 cells is achieved by a heterodimer of these transcription factors similar to that reported for human papilloma virus type 18 transcription (Thierry et al., 1992) . UMSCC-1 Nuclear Extract (µg protein)
-91 b Figure 1 The constitutive activity of the MMP-9 promoter in UM-SCC-1 cells requires an AP-1 motif and a GT box at 779 and 754, respectively. (a) UM-SCC-1 cells were transiently transfected at 70% con¯uency with 8 mg of a CAT reporter driven by the full length (670 base pairs) MMP-9 promoter or an equimolar amount of a reporter fused to the 5' deleted fragments of the MMP-9 promoter. All transfections were done in the presence of 4 mg of a b-galactosidase-expressing vector. As a control, cells were also transfected with no DNA (mock). Cells were shocked with DMSO, cultured for 48 h, harvested and assayed for b-galactosidase activity. Cell extracts, corrected for dierences in transfection eciency, were incubated at 378C with [ 14 C]chloramphenicol and acetyl coenzyme A for 8 h. The mixture was extracted with ethyl acetate and subjected to thin layer chromatography. (b) A fragment of the MMP-9 promoter spanning 7144 to +1 was end-labeled with Klenow and incubated with UM-SCC-1 nuclear extract. DNase I was subsequently added and the material electrophoresed in a DNA sequencing gel. The G and G+A ladders generated by chemical degradation are shown. The footprinted sequences on the noncoding strand are indicated. (c) UM-SCC-1 cells were transiently transfected, as described above, with a CAT reporter driven by 670 base pairs of wild type (wt), point-mutated (mt) or deleted (del) fragments of the MMP-9 promoter. Construct names indicate the binding site which was mutated or deleted and its position relative to the transcription start site. To further investigate the role of the AP-1 binding transcription factors in the regulation of MMP-9 expression, UM-SCC-1 cells were co-transfected with a CAT reporter fused to 670 base pairs of MMP-9 regulatory sequence ( Figure 2b ) and an expression construct (TAM-67) encoding a c-Jun which lacks amino acids 3 ± 122 (Brown et al., 1993) . The mutated protein inhibits AP-1-dependent gene expression through a quenching mechanism by inhibiting the function of endogenous Jun and/or Fos proteins (Brown et al., 1994) . Expression of TAM-67 caused a dose-dependent repression of the MMP-9 promoter in UM-SCC-1 cells. A threefold molar excess of the TAM-67, with respect to the reporter construct, inhibited MMP-9 promoter activity by over 80%. The ability of the mutated Jun expression construct to decrease CAT activity was retained using 241 base pairs of MMP-9 regulatory sequence in which the upstream AP-1 motif (at 7533) is absent (Figure 2c ). Figure 1a with the exception that no CAT reporter construct was added. The amounts of JNK1mt expression vector and the empty vector (CMV vector) used correspond to those stated in (b). The cells were changed to serum-free media 16 h after being shocked and the conditioned medium collected 48 h later. Conditioned medium, normalized for dierences in transfection eciency, was assayed for gelatinolysis using a 7.5% polyacrylamide gel containing 0.1% gelatin. Proteolysis was detected as a white zone in a dark ®eld. The data shown are typical of three or more dierent experiments GST-c-Jun
Regulation of MMP-9 gene expression by MAPKs R Gum et al transcription factors in the regulation of MMP-9 promoter activity, we undertook studies to identify upstream signaling molecules regulating MMP-9 expression in UM-SCC-1 cells. The role of the JNK and ERK subsets of MAPKs in the regulation of MMP-9 expression was determined since these kinases regulate the synthesis and/or activity of transcription factors which bind to the AP-1 motif (Adler et al., 1994; Cavigelli et al., 1995; Hibi et al., 1993; Minden et al., 1994b; Gille et al., 1992; Bogoyevitch et al., 1995) .
Repression of MMP-9 expression by an expression vector encoding a mutated JNK1
JNK proteins immunoprecipitated with an anti-JNK antibody reactive with human and murine JNK1 and JNK2 were highly ecient at phosphorylating a GSTc-Jun (amino acids 1 ± 79) fusion protein indicating that UM-SCC-1 cells contain an activated JNK(s) ( Figure  3a ). In contrast, NIH3T3 cells, previously shown to contain little activated JNK (Minden et al., 1996) , had substantially less kinase activity. UM-SCC-1 cells were then co-transfected with the MMP-9 promoter-driven CAT reporter and an expression vector (JNK1mt) (see Figure 4 ) encoding a dominant negative JNK1 protein (Derijard et al., 1994) . Expression of a threefold molar excess of the mutated JNK1 repressed MMP-9 promoter activity by over 50% (Figure 3b ) compared with the empty expression vector (CMV vector). To con®rm that the JNK1mt expression vector was indeed impairing AP-1-dependent gene expression, UM-SCC-1 cells were co-transfected with a CAT reporter driven by either a thymidine kinase minimal promoter (pBLCAT) or three AP-1 tandem repeats upstream of the minimal promoter (3X AP-1 pBLCAT). The thymidine kinase minimal promoter was only weakly activated in UM-SCC-1 cells (Figure 3c ). However, a strong activity was evident with the thymidine kinase minimal promoter anked by three AP-1 tandem repeats (Figure 3c ). Transfection of the UM-SCC-1 cells with amounts of the dominant negative JNK1mt expression vector, which repressed the MMP-9 promoter, similarly diminished CAT activity from the 3X AP-1 pBLCAT construct.
To determine if the mutated JNK1 expression vector modulated endogenous MMP-9 expression, we transiently transfected UM-SCC-1 cells with amounts of the JNK1mt construct which repressed the MMP-9 CAT reporter construct. After 24 h, the cells were changed to serum-free medium and incubated for an additional 2 days. The conditioned medium was subsequently collected and subjected to zymography using gelatin as substrate (Figure 3d) . A gelatinase activity, indistinguishable in size (92 kDa) from MMP-9, was detected in the conditioned medium from UM-SCC-1 cells transfected with the empty expression vector (CMV vector). However, the intensity of the band was reduced in UM-SCC-1 cells transfected with amounts of the mutated JNK1 expression construct which reduced MMP-9 promoter activity in the CAT assays.
Expression of a dominant negative MEKK represses MMP-9 promoter activity
The JNKs are, via JNKK1, activated by the serinethreonine kinase MEKK (Lin et al., 1995a; LangeCarter et al., 1993; Derijard et al., 1995) . Consequently, we determined the eect of a dominant negative MEKK expression vector (Minden et al., 1994a) (refer to Figure 4 ) on MMP-9 promoter activity. UM-SCC-1 cells were co-transfected with the MMP-9 promoter-driven CAT reporter and varying amounts of the MEKK mutant (MEKKmt) or an equivalent amount of the empty expression vector (Sra Vector). Expression of an equimolar amount of the MEKKmt repressed MMP-9 promoter activity by approximately 50% when compared with the empty vector (Sra Vector) (Figure 5a) . A twofold molar excess of the MEKKmt was slightly more active in this regard. Similarly, both a one-and twofold molar excess of the MEKKmt expression vector inhibited the activation of the 3X AP-1 pBLCAT reporter construct indicating regulation of AP-1-dependent gene expression ( Figure  5b ). Put together, these data indicate a role for a JNKdependent signaling module in the regulation of MMP-9 expression.
Repression of MMP-9 expression by a mutant ERK1 expression construct
Considering that ERK1 is constitutively activated in UM-SCC-1 cells , we also investigated the role of this MAPK in the regulation of MMP-9 expression. ERK1 increases the synthesis of c-Fos via the phosphorylation of p62
Tcf/Elk (Gille et al., 1992) . To determine if MMP-9 promoter activity was regulated by this MAPK, we made use of a construct (mt ERK1 pCEP 4 ) encoding a kinase-inactive ERK1 (Frost et al., 1994) . Expression of the mtERK1 pCEP 4 inhibited the activity of the MMP-9 promoter-driven CAT reporter with a twofold molar excess reducing [ 14 C]chloramphenicol acetylation by 70% (Figure 6a) . Parallel experiments using a CAT reporter driven by a minimal promoter consisting of three tandem AP-1 repeats upstream of a thymidine kinase promoter were conducted to con®rm that the mutated ERK1 expression construct was indeed repressing AP-1 activity. Transfection of the kinase-defective ERK1 expression construct into UM-SCC-1 cells reduced the activity of the AP-1-thymidine kinase minimal promoter (Figure 6b ) over the same concentration range that attenuated MMP-9 promoter activity. UM-SCC-1 cells were then transiently transfected with the mutant ERK1 or the empty expression vector (pCEP 4 ). The transfected cells were changed to serum-free medium 24 h later and incubated for an additional 48 h. The conditioned medium was subsequently subjected to zymography using gelatin as substrate (Figure 6c) . A reduced gelatinolysis at the 92 kDa position was apparent with the conditioned medium from the ERK1 mutant-transfected cells compared with cells made to express the empty vector (pCEP 4 ).
Reduction in MMP-9 enzyme activity/promoter activity by the MEK1-speci®c inhibitor (PD 098059) and by a dominant negative expression vector Since ERK1 is a downstream eector of the dual activity protein kinase MEK1 (Crews et al., 1992) , we tested the possibility that MMP-9 expression was regulated through this ERK1 activator. Two experiments were carried out. First, UM-SCC-1 cells were Regulation of MMP-9 gene expression by MAPKs R Gum et al treated for 4 days with dierent concentrations of a speci®c inhibitor of MEK1 (PD 098059 ± refer to Figure 4 ) Alessi et al., 1995) or an equivalent amount of the DMSO carrier, the conditioned medium collected and assayed for gelatinolysis (Figure 7a) . Concentrations of the agent, which have been shown to block MEK1 (Alessi et al., 1995; Lin et al., 1995b) , were highly eective at reducing 92 kDa gelatinolysis (compared with the paired amount of carrier alone). In this particular experiment we also detected a 72 kDa gelatinase, which was indistinguishable in size from MMP-2 (gelatinase A) (Huhtala et al., 1990) . However, this enzyme activity was not diminished by the PD 098059 (compared with the equivalent amount of DMSO) indicating speci®city of this drug for 92 kDa gelatinolysis. The concentrations of PD 098059 used in the current study did not retard the growth of the cells.
Second, we asked whether transfection of UM-SCC-1 cells with a dominant negative MEK1 expression vector (Mansour et al., 1994) altered MMP-9 promoter activity. UM-SCC-1 cells were co-transfected with the MMP-9 promoter-driven CAT reporter and dierent amounts of an expression vector encoding either the wild type (MEK1 wt) or a mutated (MEK1 K97M) MEK1 sequence. A threefold molar excess of the dominant negative expression vector reduced MMP-9 promoter activity by approximately 50% relative to an equivalent amount of the MEK1 wt expression construct (Figure 7b ).
Expression of a kinase-de®cient c-Raf-1 represses the MMP-9 promoter
The activity of MEK1 is controlled by the serinethreonine kinase c-Raf-1 and we determined the eect of a kinase-de®cient c-Raf-1 expression construct (Raf C4) (Bruder et al., 1992) on the regulation of MMP-9 promoter activity in UM-SCC-1 cells. Towards this end, UM-SCC-1 cells were co-transfected with varying amounts of the Raf C4 expression vector or the empty vector (Vector) and a CAT reporter driven by either the MMP-9 promoter (Figure 8a ) or by three tandem AP-1 repeats upstream of a thymidine kinase minimal promoter (Figure 8b ). Raf C4 expression in UM-SCC-1 cells repressed, in a dose-dependent manner, MMP-9 promoter activity (Figure 8a ). The reduced MMP-9 promoter activity coincided with the diminished activity of the AP-1-regulated CAT reporter ( Figure  8b ).
We then asked whether stimulation of c-Raf-1 by phorbol ester treatment was inductive for MMP-9 expression. The phorbol ester PMA (phorbol 12-myristate 13-acetate) binds to protein kinase C which in turn activates c-Raf-1 (Sozeri et al., 1992) . Treatment of UM-SCC-1 cells with PMA caused a dose-dependent increase in MMP-9 activity ( Figure   Figure 4 Diagrammatic representation of the targets of the dominant negative expression constructs and PD 098059. The JNK and ERK-dependent signaling cascades leading to altered synthesis and/or activity of AP-1-binding proteins are shown. An arrow with an X indicates the molecule targeted by the dominant negative expression constructs or by PD 098059 a b Figure 5 Repression of MMP-9 promoter activity by a dominant negative MEKK expression vector in UM-SCC-1 cells. UM-SCC-1 cells were transiently transfected and assayed for CAT activity, as described in the legend to Figure 3b Regulation of MMP-9 gene expression by MAPKs8c). Together these data indicate a role for an ERKdependent signaling pathway in the regulation of MMP-9 expression in UM-SCC-1 cells.
Discussion
The 92 kDa type IV collagenase plays a critical role in tumor cell invasion (DeClerck et al., 1992; Anderson et al., 1996; Cha et al., 1996) by virtue of its ability to hydrolyze type IV collagen present in basement membranes. While studies by other investigators have identi®ed a diverse set of exogenous agents including EGF, TNF-a, the v-src oncogene as well as phorbol ester which induce the synthesis of this enzyme there have been no studies investigating the signaling events connecting the cell surface to the transcriptional machinery regulating the expression of this gene. To the knowledge of the authors, this is the ®rst demonstration of a role for JNK-and ERKdependent signaling cascades in the regulation of MMP-9 expression.
Our data are consistent with the notion that the regulation of MMP-9 expression in UM-SCC-1 cells by the JNK-and ERK-dependent signaling modules is, at least in part, through the modulation in the synthesis and/or activity of AP-1-binding proteins. However, we can only speculate as to the identity of the AP-1-binding transcription factor(s) targeted by either of these signaling cascades. Certainly, a likely candidate is c-Fos since the gel shift assays revealed this transcription factor bound to the AP-1 motif at 779. Indeed, the synthesis of c-Fos is regulated both by the JNK- (Whitmarsh et al., 1995; Cavigelli et al., 1995) and the ERK- (Gille et al., 1992) dependent signaling modules via the phosphorylation of p62 Tcf/Elk . In fact, Whitmarsh and co-workers (Whitmarsh et al., 1995) have concluded that the serum-response element (in the c-Fos promoter) represents a point of convergence of the JNK and ERK-dependent signaling modules. It should be emphasized, however, that our studies do not rule out the possibility that the regulation of MMP-9 expression by the JNK-and ERK-dependent signaling cascades also requires transcription factors binding to non-AP-1 motifs necessary for optimal promoter activation in UM-SCC-1 cells (e.g. the GT box at 754 or the NF-kB motif at 7600). Nevertheless, the observations that MMP-9 promoter activity is reduced substantially either by the co-expression of a construct (TAM-67), which interferes with the ability of endogenous Fos and Jun proteins to transactivate AP-1 controlled genes, or by mutation of the AP-1 motif at 779 strongly suggest a role for AP-1-binding proteins in the regulation of expression of this collagenase in UM-SCC-1 cells. Figure 3 using a CAT reporter driven by either the wild type MMP-9 promoter (MMP-9 CAT) (a) or 3 tandem AP-1 repeats upstream of a thymidine kinase minimal promoter (36AP-1 pBLCAT) (b) and the indicated amount (where 26 is a twofold molar excess of the eector plasmid relative to the reporter construct) of an expression vector encoding a dominant negative c-Raf-1 protein (Raf C4) or the empty vector (Vector). Cell extracts, normalized for dierences in transfection eciencies, were assayed for CAT activity. (c) UM-SCC-1 cells at 75% con¯uency were changed to serum free medium supplemented with, or without, the indicated concentration of PMA and cultured for 48 h. After this time, the conditioned medium was harvested and centrifuged to remove cellular debris. Cell numbers were determined. Aliquots of the conditioned medium, corrected for dierences in cell number, were assayed for MMP-9 activity by zymography as described in the legend to Figure 3d . The experiment was carried out three times
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We were initially surprised by the requirement of a JNK in the regulation of MMP-9 expression since the ®rst member of this MAPK subgroup (JNK1) was originally identi®ed as being rapidly induced in response to ultraviolet light or osmotic stress (Derijard et al., 1994) . However, in the pioneering studies (Derijard et al., 1994) , while the authors demonstrated ultraviolet light to be the most eective stimulus for JNK activation, a threefold induction of this kinase was observed with EGF. Indeed, it is now becoming apparent that this signaling kinase may be implicated in the regulation of expression of at least some inducible genes. For example, Xie and Herschman (1995) recently reported that the induction of prostaglandin synthase 2 gene expression by v-src was via activation of JNK1 and through the c-Jun transcription factor. Further, Khosravi-Far and coworkers demonstrated that the oncogenic transformation of NIH3T3 cells by Ras could be antagonized by the co-expression of Rac1 (Khosravi-Far et al., 1995) . Rac1 is, via MEKK, an upstream activator of JNK (Minden et al., 1996) . Our ®ndings could provide an explanation as to how a diverse set of stimuli including the v-src oncogene , IL-1 (Hurwitz et al., 1993; Lyons et al., 1993; Unemori et al., 1991) and TNF-a all induce MMP-9 expression. Recent studies have shown that IL-1 treatment increases JNK activity (Bagrodia et al., 1995) and TNF-a also causes a rapid stimulation of this kinase while only weakly inducing the ERK subset of MAPK at least in HL 60 cells (Westwick et al., 1995) . Likewise, v-src is a potent inducer of JNK1 (Xie and Herschman, 1995) . Since our studies demonstrated a clear involvement of a JNK(s) in the regulation of MMP-9 expression it may very well be that the ability of these cytokines and the v-src oncogene to induce the expression of this collagenase is mediated through this MAPK subset. On the other hand, phorbol ester, which is also a potent stimulus for MMP-9 expression is, via c-Raf-1 (Sozeri et al., 1992) , an ERK1, but not a JNK (Cavigelli et al., 1995; Bogoyevitch et al., 1995) activator. Thus, it is more likely that its inductive eects on synthesis of this collagenase is propagated along an ERK-dependent signaling cascade. Indeed, this contention is given further support by the studies of Sato and co-workers showing dierent transcription factor binding site requirements for MMP-9 induction by v-src and by phorbol ester . In those studies, the authors demonstrated that while the induction of MMP-9 expression by v-src was mediated through a 90 base pair sequence containing the proximal AP-1 (779) motif and a GT box (754), increased promoter activity brought about by PMA treatment required the AP-1 (779), NF-kB (7600) and Sp1 (7558) motifs but not the GT box at 754 .
The current study may also shed light onto the mechanism by which Ha-Ras activates MMP-9 expression in the OVCAR-3 ovarian cancer cells as previously reported by this laboratory . In that study, we demonstrated that the induction of MMP-9 expression in OVCAR-3 cells by Ha-Ras utilized a MAPK-dependent signaling pathway as evidenced by the ability of a phosphatase (CL100), which inactivates multiple MAPK members (including ERK and JNK members) (Liu et al., 1995; Alessi et al., 1993; Chu et al., 1996) to counter this induction. In contrast, interfering with the ERK activator MEK1 by employing a dominant negative MEK1 expression vector had little eect on the induction of MMP-9 promoter activity by Ha-Ras suggesting the involvement of MAPK(s) other than ERK1/ERK2.
The idea that the expression of inducible genes can be regulated by multiple signaling modules which terminate in activated AP-1-binding transcription factors is not unprecedented. Zohn and others (1995) reported that angiotensin II, like EGF, was capable of activating both the ERK and JNK subsets of MAPK in GN4 rat liver epithelial cells albeit with dierent potencies. Further, in a report by Khosravi-Far et al. (1995) it was demonstrated that the activity of a weakly transforming c-Raf-1 was enhanced 35-fold by the co-expression of a constitutively activated Rac1 the latter being an upstream activator of the JNK pathway (Minden et al., 1996; Olson et al., 1995) . Finally, Bogoyevitch and others (1995) reported that endothelin-1, a known activator of the ERKs, also transiently stimulated JNKs two ± ®vefold in ventricular myocytes. We can only speculate that the ability of the cell to employ more than one signaling module to control MMP-9 expression may provide it with a means of responding to a diverse set of growth factors/cytokines and/or environmental conditions.
In conclusion, the study herein, suggests that MMP-9 expression in UM-SCC-1 cells is regulated by JNKand ERK-dependent signaling modules. These ®ndings raise the exciting possibility that interfering with either, or both, of these pathways could reduce MMP-9 synthesis in invasive cancer (Pyke et al., 1992; Nakajima et al., 1993; and in in¯ammatory disorders such as rheumatoid arthritis (Unemori et al., 1991) .
Materials and methods

Materials
The following antibodies used in mobility shift assays were purchased from Santa Cruz Biotechnology: # SC 6056 which is speci®c for Fra-1; # SC 526 which reacts speci®cally with c-Fos; # SC 6046 which speci®cally reacts with Fra-2; # SC 8226 directed against c-Jun; # SC 466 which speci®cally recognizes Jun-B; and # SC 1876 which reacts with ATF-2. The speci®c anti-Jun-D antibody was kindly provided by Dr Moshe Yaniv, (Pasteur Institute, Paris, France).
Cell culture
UM-SCC-1 cells derived from a squamous cell carcinoma of the oral cavity were obtained from Dr Thomas Carey at the University of Michigan. All cells were maintained in McCoy's 5A medium containing 10% FBS with the exception of conditioned medium collection which was performed using McCoy's 5A medium supplemented with 4 mg/ml transferrin, 5 mg/ml insulin and 10 ng/ml EGF (serum-free medium).
DNA constructs
The TAM-67 vector, encoding a c-Jun protein lacking the transactivation domain (amino acids 3 ± 122 absent) of the molecule, has been described elsewhere (Brown et al., 1993; Domann et al., 1994) . The Raf C4 expression vector encodes a mutated c-Raf-1 lacking the kinase domain of the serine-threonine kinase (Bruder et al., 1992) . The ERK1 construct encodes the ERK1 cDNA in which the conserved lysine at codon 71 was changed to arginine thus impairing the catalytic eciency (Frost et al., 1994) . The dominant negative JNK1 used herein includes the coding sequence in which threonine 183 and tyrosine 185 are substituted with alanine or phenylalanine respectively (Derijard et al., 1994) . The mutated MEKK expression construct encodes a MEKK cDNA harboring a lysine to methionine substitution at residue 432 and lacking the Nco fragment from the aminoterminus (Minden et al., 1994a) . The MEK1 K97M expression construct encodes the MEK1 sequence in which a lysine at codon 97 is replaced with a methionine residue (Mansour et al., 1994) . The 36AP1 pBLCAT construct consists of three AP-1 tandem repeats upstream of a thymidine kinase minimal promoter-CAT reporter (pBLCAT) (Angel et al., 1988) . The wild type, mutated and 5' deleted MMP-9 promoter fragments have been described elsewhere Gum et al., 1996) .
Chloramphenicol acetyl transferase (CAT) assays
UM-SCC-1 cells were co-transfected at 70% con¯uency with CAT reporter constructs and 4 mg of an expression vector bearing the b-galactosidase gene. DNA dissolved in 1 ml of HBS buer (25 mM HEPES, 1 mM MgCl 2 , 0.1 mM CaCl 2 , 0.1 M NaCl, 5 mM KCl and 0.7 mM Na 2 HPO 4 , pH 7.44) was mixed with 50 mg hexadimethrine bromide (Polybrene, Aldrich Chemicals, WI) and added to the cells in 5 ml of 10% FBS. After 6 h the cells were shocked for 4 min with 34% DMSO and cultured for an additional 48 h. The cells were then harvested and lysed by repeated freeze-thaw cycles in a buer containing 0.25 M Tris-Cl pH 7.8. Transfection eciencies were determined by assaying for b-galactosidase activity. CAT activity was subsequently measured by incubating cell lysate (normalized for transfection eciency) at 378C for 8 h (unless otherwise stated) with 4 mM [ 14 C]chloramphenicol and 1 mg/ml acetyl coenzyme A. After 4 h, the acetyl coenzyme A was replenished. The acetylated products were extracted with ethyl acetate and were subjected to thin layer chromatography using chloroform/methanol (95:5) as the mobile phase. The amount of acetylated [
14 C]chloramphenicol was determined using a 603 Betascope.
DNase I footprinting
Nuclear extracts were prepared according to methods previously published (Dignam et al., 1983) . Brie¯y, cells (^10 9 ) were collected, washed with PBS and the packed cell volume determined. The cells were resuspended in buer A (10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 2 mM DTT) and lysed with a Dounce homogenizer. Nuclei were collected by centrifugation and resuspended in a 1/2 volume of a buer (C) containing 20 mM HEPES (pH 7.9), 20% glycerol, 0.6 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM PMSF and 2 mM DTT. Nuclei were fractured using a Dounce pestle, stirred for 30 min at 48C and then centrifuged. The supernatant (nuclear extract) was retained and dialyzed against 100 volumes of a buer containing 20 mM HEPES pH 7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 5 mM MgCl 2 and 2 mM DTT. The extract was centrifuged for 20 min and aliquots frozen at 7808C until required.
An MMP-9 promoter CAT reporter plasmid containing nucleotides +1 to 7144 (Sato and Seiki, 1993) of the promoter was digested with Asp718 and PstI. The digested DNA was labeled with Klenow then electrophoresed in a 5% polyacrylamide gel. The DNA fragment was isolated, and puri®ed by sodium acetate/ethanol precipitation. Endlabeled DNA (15 ng) was mixed with poly (dI-dC), nuclear extract and transcription buer (20 mM HEPES, 100 mM KCl, 2 mM EDTA, 5 mM MgCl 2 , 1.5 mM DTT) in a total volume of 20 ml. Binding was allowed to proceed for 15 min at room temperature after which DNase I (®nal concentration 10 mg/ml) was added. A stop solution (100 ml) containing 10 mM EDTA, 0.1% SDS and 50 mg/ml of proteinase K was added 30 s later and the mixture incubated at 378C for 30 min. The mixture was extraced with phenol/chloroform, precipitated, washed with 70% ethanol and dried. The material was dissolved in denaturing solution containing formamide and electrophoresed in a DNA sequencing gel.
Electrophoretic mobility shift assays (EMSA)
Nuclear extract was prepared as described previously (Schreiber et al., 1989) . Cultured cells were collected by centrifugation, washed and resuspended in a buer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT and 0.5 mM-PMSF. After 15 min on ice, the cells were vortexed in the presence of 0.6% Nonidet NP-40. The nuclear pellet was then collected by centrifugation and extracted in a buer containing 20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 1 mM PMSF for 15 min at 48C. The extract was centrifuged and the supernatant frozen at 7808C until needed.
Nuclear extract (10 mg) was incubated at 218C for 10 min, with shaking, in a buer (25 mM HEPES buer pH 7.9, 0.5 mM EDTA, 0.5 mM DTT, 0.05 M NaCl and 2.5% glycerol) containing 2 mg of poly dI/dC and 5 fmoles (3610 4 c.p.m.) of a Klenow end-labeled [a 32 P]ATP oligonucleotide (spanning nucleotides 791 to 760 relative to the transcriptional start site) in the absence, or presence, of a 100-fold excess of the wild type or mutated competitor sequence. After this time 1 mg of the indicated antibody was added and the incubation continued for 10 min. The reaction mixture was electrophoresed in a 5% polyacrylamide gel, containing 5% glycerol using 0.56TBE (89 mM Tris, 89 mM boric acid and 1 mM EDTA) running buer. The gel was rinsed with water, dried and exposed to X-ray ®lm overnight.
JNK activity assays
JNK activity was determined as described elsewhere (Coso et al., 1995) . Cell extracts prepared in a buer containing (1% Triton X-100, 25 mM HEPES pH 7.6, 300 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EGTA, 0.5 mM DTT, 0.5% sodium deoxycholate, 0.1% SDS, 20 mM b-glycerophosphate, 20 mg/ml aprotinin, and 20 mg/ml leupeptin, 1 mM PMSF, 1 mM sodium vanadate) were incubated at 48C for 2 h with 1.5 mg of an anti-JNK antibody (Santa Cruz Biotechnology # sc-474) which is crossreactive with mouse and human JNK1 and JNK2. Protein A agarose beads were then added to the mixture and incubated for an additional 1.5 h at 48C. The beads were rinsed several times as described elsewhere (Coso et al., 1995) and then incubated in 30 ml of kinase buer (12.5 mM MOPS (pH 7.5), 7.5 mM MgCl 2 , 12.5 mM b-glycerophosphate, 0.5 mM EGTA, 0.5 mM NaF, 0.5 mM sodium vanadate) with 1 mCi [g 32 P]ATP, 2 mg GSTc-Jun protein (amino acid residues 1 ± 79 of c-Jun) and 20 mM cold TP at 308C. The reaction was terminated 20 min later with 26Laemmli's buer, the reaction mixture heated to 1008C for 5 min and the beads removed by centrifugation. The supernatant (65 ml) was electrophoresed in a 12% polyacrylamide gel. The gel was dried and autoradiographed for 6 h.
Zymography
These were performed as described previously . Culture supernates were denatured in the absence of reducing agent and electrophoresed in a 7.5% polyacrylamide gel containing 0.1% (w/v) gelatin. The gel was incubated at room temperature for 2 h in the presence of 2.5% Triton X-100 and subsequently at 378C overnight in a buer containing 10 mM CaCl 2 , 0.15 M NaCl, and 50 mM Tris (pH 7.5). The gel was then stained for protein with 0.25% Coomassie and photographed on a light box. Proteolysis was detected as a white zone in a dark ®eld.
